PREMIUM PHARMA
De berekende faillissementskans van PREMIUM PHARMA over 12 maanden bedraagt 0,7% (laag). Het bedrijf is actief sinds 2008 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 18 jaar |
| Vestigingen | 2 |
| Publicaties | 3 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | micro | 31-10-2025 | 2025-00559161 |
| 31-12-2023 | micro | 28-06-2024 | 2024-00185119 |
| 31-12-2022 | micro | 30-06-2023 | 2023-00188791 |
| 31-12-2021 | micro | 30-06-2022 | 2022-20118975 |
| 31-12-2020 | micro | 05-08-2021 | 2021-46800281 |
| 31-12-2019 | micro | 29-10-2020 | 2020-65300420 |
| 31-12-2018 | micro | 28-08-2019 | 2019-56000570 |
| 31-12-2017 | micro | 29-08-2018 | 2018-58000211 |
| 31-12-2016 | micro | 31-08-2017 | 2017-56300009 |
| 31-12-2015 | volledig | 29-06-2016 | 2016-26900437 |
| NACE primair | 82300 |
| Rechtsvorm | BV(610) |
| Oprichtingsdatum | 12-03-2008 |
| Status | Actief |
| Postcode | 1050 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 23094D0045/00Z003 | Vlaanderen | 6.720 m² | 1 · 1.394 m² | 11,2 m · 2 verd. |
| 21807G0089/00A006 | Brussel | 349 m² | 1 · 310 m² | 28,7 m · 9 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
08-06-2026 General meeting · Seat change · Approval · Officer appointment
- Filing: 2026-05-29 · Premium Pharma
- Publication: 2026-06-08 · Premium Pharma
- General meeting: date: 2026-03-20, type: Assemblée Générale Extraordinaire · Premium Pharma
- Seat change: new_address: Avenue Louise 163 1050 BRUXELLES, old_address: Avenue Jean Monnet 1-1401 NIVELLES, decision_date: 2026-03-20 · Premium Pharma
- Approval: date: 2025-10-31, description: transfert du siège social à la fin du contrat de domiciliation avec Nivaxis Gate S.A. · Premium Pharma
- Officer appointment: role: Administrateur · Olivier LEBBINK
- Act object: Transfert et modification du siège social
Technische details
{
"facts": [
{
"type": "filing",
"quote": "TRIBUNAL DE L\u0027ENTREPRISE 29 MAI 2026",
"value": "2026-05-29",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 08/06/2026 - Annexes du Moniteur belge",
"value": "2026-06-08",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Extrait du Proc\u00E8s - Verbal de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire de la SRL Premium Pharma tenue le 20 mars 2026.",
"value": {
"date": "2026-03-20",
"type": "Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire"
},
"object": null,
"subject": "e1"
},
{
"type": "seat_change",
"quote": "le transfert et la modification du si\u00E8ge social est confirm\u00E9 par la pr\u00E9sente \u00E0 l\u0027adresse suivante Avenue Louise 163 1050 BRUXELLES",
"value": {
"new_address": "Avenue Louise 163 1050 BRUXELLES",
"old_address": "Avenue Jean Monnet 1-1401 NIVELLES",
"decision_date": "2026-03-20"
},
"object": null,
"subject": "e1"
},
{
"type": "approval",
"quote": "L\u0027Assembl\u00E9e du 31/10/2025 avait approuv\u00E9 le transfert du si\u00E8ge social \u00E0 la fin du contrat de domiciliation avec Nivaxis Gate S.A.",
"value": {
"date": "2025-10-31",
"description": "transfert du si\u00E8ge social \u00E0 la fin du contrat de domiciliation avec Nivaxis Gate S.A."
},
"object": null,
"subject": "e1"
},
{
"type": "officer_appointment",
"quote": "Olivier LEBBINK Administrateur",
"value": {
"role": "Administrateur"
},
"object": "e1",
"subject": "e2"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Transfert et modification du si\u00E8ge social",
"value": "Transfert et modification du si\u00E8ge social",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1911,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0896.401.843",
"kind": "company",
"name": "Premium Pharma",
"attrs": {
"new_seat": "Avenue Louise 163 1050 BRUXELLES",
"old_seat": "Avenue Jean Monnet 1-1401 NIVELLES",
"legal_form": "SRL"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Olivier LEBBINK",
"attrs": {
"role": "Administrateur"
}
},
{
"id": "e3",
"kbo": null,
"kind": "company",
"name": "Nivaxis Gate S.A.",
"attrs": {
"status": "soci\u00E9t\u00E9 de service - ouverture de faillite"
}
}
]
}23-01-2025 Zetelverplaatsing van Jemeppe-sur-Meuse naar NIVELLES
- Rue Antonin Delville 140, 4101 Jemeppe-sur-Meuse → Avenue Jean Monnet 1, 1401 NIVELLES
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "NIVELLES",
"region": null,
"street": "Avenue Jean Monnet",
"country": "BE",
"postcode": "1401",
"box_number": null,
"street_number": "1"
},
"old_address": {
"city": "Jemeppe-sur-Meuse",
"region": null,
"street": "Rue Antonin Delville",
"country": "BE",
"postcode": "4101",
"box_number": "B",
"street_number": "140"
},
"effective_date": "2024-10-24",
"evidence_quote": "L\u0027Assembl\u00E9e approuve le transfert du si\u00E8ge social de la soci\u00E9t\u00E9 \u00E0 partir du 24 octobre 2024 \u00E0 l\u0027adresse suivante: Centre d\u0027Affaire - Hello Center PREMIUM PHARMA srl Avenue Jean Monnet, 1 1401 NIVELLES"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0896.401.843",
"name_full": "PREMIUM PHARMA",
"legal_form": "SRL"
}
}18-09-2019 Zetelverplaatsing van Bruxelles naar Jemeppe-sur-Meuse
- Avenue Louise 149, 1050 Bruxelles → Rue Antonin Delville 140, 4101 Jemeppe-sur-Meuse
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Jemeppe-sur-Meuse",
"region": "R\u00E9gion wallonne",
"street": "Rue Antonin Delville",
"country": "BE",
"postcode": "4101",
"box_number": "B",
"street_number": "140"
},
"old_address": {
"city": "Bruxelles",
"region": "Bruxelles",
"street": "Avenue Louise",
"country": "BE",
"postcode": "1050",
"box_number": "24",
"street_number": "149"
},
"effective_date": "2019-08-26",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de transf\u00E9rer le s\u00ED\u00E8ge social et l\u0027unit\u00E9 d\u0027\u00E9tablissement de Bruxelles (1050 Bruxelles), Avenue Louise, 149/24 - Centre d\u0022Affaires - Multiburo Business Center \u00E0 4101 Jemeppe-sur-Meuse, Rue Antonin Delville, 140B, avec prise d\u0027effet au 26 ao\u00FBt 2019."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0896.401.843",
"name_full": "PREMIUM PHARMA",
"legal_form": "SPRL"
}
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | PREMIUM PHARMA |